RADHIKA PATEL: Open Payments
NPI 1326013061 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 49 payments from 9 companies in 2025. Trend: 2023 $752 · 2024 $544 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $206 |
| E.R. Squibb & Sons, L.L.C. | 9 | $203 |
| Alkermes, Inc. | 10 | $190 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| ABBVIE INC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $18 |
Products named: COBENFY, ARISTADA, UZEDY, AUSTEDO XR, INVEGA SUSTENNA, INGREZZA, ABILIFY MAINTENA, CAPLYTA.
Industry payments across SC — which companies pay providers there.
